Conferences  >  Medicine & Healthcare  >  Oncology  >  United States

Keystone Symposia

This conference focuses attention on the cancer cell itself, exploring the cell-intrinsic mechanisms that drive carcinogenesis and cancer progression. The meeting emphasizes understanding how genetic, epigenetic, and metabolic changes within cancer cells contribute to tumor evolution, heterogeneity, and plasticity, in order to provide new insights into potential strategies for therapeutic interventions. While other meetings in the field focus on the tumor microenvironment and crosstalk between cells within the tumor, this meeting will take a distinct approach to pinpoint cancer cell vulnerabilities, and therapeutic strategies targeting intrinsic pathways. By bringing together experts from academia, industry, and medicine to examine the underpinnings of tumor development and evolution, we will inspire new approaches to cancer treatment.

Cleveland Clinic

This CME activity will provide a comprehensive update on current and emerging applications of stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS). Through expert-led lectures, case discussions, and debates, participants will review advances in clinical practice, technology integration, and research related to brain, spine, functional, and vascular radiosurgery. A broad range of organ-specific technical and clinical experience will be presented with opportunities to interact with faculty and system vendors.

Phone: [2163859076];     Email: eatonl3@ccf.org

oncology, neurology, neurosurgery, dosimetry, medical physics, radiation oncology, research, stereotactic radiation therapy, stereotactic radiosurgery

Continuing Medical Education (CME),    Neurology

eMedEd

The Cancer Care and Cardiology Conference 2026 is a multidisciplinary CME event bringing together cardiologists, oncologists, and healthcare professionals to discuss advances in cardio-oncology, management of cardiotoxicity, and collaborative approaches to patient care.

Conference Secretariat;     Phone: [+1-555-123-4567];     Email: info@emedevents.com

advanced cardiology care, Cancer Care, cardiological care, cardiology care, cardiology cme, Cardiology CME Conferences, cardiology cme courses​, Cardiology Conference, Cardiology Conference 2026, Cardiology Conferences 2026, care oncology, clinical care oncology, CME Cardiology, cme oncology, emedevents, International Oncology Conference, medical oncology conference, Ohio CME, Ohio CME Conference, Oncology Care, oncology cme, oncology conference, oncology conferences usa, oncology nursing conference

Keystone Symposia

This meeting will present work that encompasses the influence of hormones on driving cancer across the lifespan, through influences on aging, immunity, and other factors. Many current studies in aging and cancer do not adequately consider the impact of hormones, hormone receptors, and changing hormone levels as drivers of these processes. This meeting will assemble researchers across the fields of endocrinology, aging, and oncology to discuss the interplay of these multiple factors and how they should be considered when diagnosing and treating cancers. The meeting will span basic, translational, and clinical research to drive bench to bedside and bedside and back insights that will advance our understanding of cancer etiology, prevention, and treatment approaches. The meeting will bridge interdisciplinary groups of scientists, population scientists, and clinicians, allowing a unique blend of discovery in the hormones over the lifespan, aging, immunity, and cancer.

Cancer, Hormones, Endocrinology, Oncology, Aging, Immunology, Bench to Bedside, Clinical Research, Translational Research

Biology,    Immunology and Allergic Diseases

Keystone Symposia

Cancer Immunotherapy: Bridging Basic Research and Clinical Translation brings together immunologists, oncologists, bioengineers, and translational scientists to accelerate the next generation of cancer therapies. The meeting spotlights immune-based approaches spanning foundational discovery to clinical application, highlighting how insights from basic biology are reshaping cancer treatment. Program sessions showcase advances in checkpoint therapies, cellular and engineered immunotherapies, cancer vaccines, and tumor microenvironment, and emphasize how innate and adaptive immune responses can be harnessed and optimized to improve therapeutic outcomes.

Cancer, Immunotherapy, Oncology, Biomedical Engineering, Bioengineering, Therapeutics, Translational Research, Protein Engineering

Molecular Biology,    Biotechnology